| Diabetic Kidney Disease | 2017/05/18 | English | 77 |
| World Incidence of AKI | 2013/09/01 | English | 37 |
| Normal Bone Anatomy and Physiology | 2008/11/01 | English | 29 |
| Primary Membranous Nephropathy | 2017/05/26 | English | 23 |
| Aspects of Immune Dysfunction in End-stage Renal Disease | 2008/09/01 | English | 21 |
| Update on Lupus Nephritis | 2016/11/07 | English | 21 |
| Diagnosis and Management of Type 2 Diabetic Kidney Disease | 2017/03/09 | English | 19 |
| IgA Nephropathy | 2017/02/03 | English | 19 |
| Calcineurin Inhibitor Nephrotoxicity | 2009/02/01 | English | 17 |
| Circulating Endotoxemia | 2011/01/01 | English | 14 |
| Incidence, Outcomes, and Comparisons across Definitions of AKI in Hospitalized Individuals | 2014/01/01 | English | 13 |
| Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients | 2009/10/01 | English | 13 |
| Nephrotoxicity and Chinese Herbal Medicine | 2018/04/03 | English | 13 |
| Influence of Muscle Mass and Physical Activity on Serum and Urinary Creatinine and Serum Cystatin C | 2008/03/01 | English | 13 |
| Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC | 2012/12/01 | English | 13 |
| Renal Control of Calcium, Phosphate, and Magnesium Homeostasis | 2015/07/01 | English | 13 |
| Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk | 2010/08/01 | English | 12 |
| Focal Segmental Glomerulosclerosis | 2017/02/27 | English | 12 |
| Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines | 2016/04/19 | English | 11 |
| Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient | 2008/03/01 | English | 11 |
| Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China | 2020/05/22 | English | 10 |
| Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype | 2010/10/01 | English | 10 |
| Obesity and Obesity-Initiated Metabolic Syndrome | 2007/05/01 | English | 10 |
| Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD | 2016/04/19 | English | 10 |
| Donor-Specific Antibodies in Kidney Transplant Recipients | 2017/04/26 | English | 10 |
| Comparative Associations of Muscle Mass and Muscle Strength with Mortality in Dialysis Patients | 2014/10/01 | English | 10 |
| Symptom Burden, Depression, and Quality of Life in Chronic and End-Stage Kidney Disease | 2009/06/01 | English | 10 |
| Minimal Change Disease | 2016/12/09 | English | 10 |
| Inflammation and Progression of CKD: The CRIC Study | 2016/06/23 | English | 9 |
| Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986–2015 | 2017/03/21 | English | 9 |